Dermapharm

#3492

Rank

$2.6B

MarketCap DE

DE Germany

Country

Summary
Dermapharm Holding SE, together with its subsidiaries, engages in the off-patent branded pharmaceuticals business in Germany and internationally. It operates through three segments: Branded Pharmaceuticals and Other Healthcare Products, Parallel Import Business, and Herbal Extracts. The company develops, manufactures, licenses, markets, and sells branded generics, over-the-counter drugs, non-prescription natural remedies, and other healthcare products. It also offers healthcare products in the areas of vitamins, minerals, food supplements, dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology primarily under the Dekristol, Dekristolvit, Allergovit, and Tromcardin brands. In addition, the company provides medical devices under the bite away and Herpotherm names; Momekort, a nasal spray used to treat allergy symptoms; and Azedil, a nasal spray or eye drop. Further, it imports originator pharmaceuticals under the axicorp brand; and offers herbal extracts and natural active ingredients for phytopharmaceuticals, nutraceuticals, and cosmetics. It serves pharmaceutical wholesalers, pharmacies, hospitals, and health food stores. The company was founded in 1991 and is headquartered in Grünwald, Germany. Dermapharm Holding SE is a subsidiary of Themis Beteiligungs-Aktiengesellschaft.

History

Dermapharm was founded in 1981 and is headquartered in Munich, Germany. Since then, Dermapharm has become one of the most successful specialty pharmaceutical companies in Germany. Over the years, the company has developed and launched numerous successful products and has established a long-term and successful collaboration with leading pharmaceutical companies.


Mission
With innovative drugs and medical care products, Dermapharm's mission is to improve the quality of life of our customers, be it physicians, pharmacists or patients.

Vision
Dermapharm wants to be a leading specialty pharmaceutical company in Europe. By providing innovative products, the company continues to meet the ever-evolving needs of its customers and create value for them in a trustworthy and responsible manner.

Key Team

Ms. Britta Hamberger (Head of Investor Relations & Corp. Communications)

Dr. Andreas Eberhorn (Chief Marketing Officer)


Recognition and Awards
Dermapharm has received numerous awards for its outstanding quality and efforts. Most recently, it was awarded the German SME Awards for its excellence in the field of research and development. It has also won several international awards for its dedication to the pharmaceutical industry.

References
Dermapharm
Leadership team

Dr. Hans-George Feldmeier (CEO & Chairman of the Management Board)

Ms. Karin Samusch (Member of the Management Board & Chief Bus. Devel. Officer)

Mr. Christof Dreibholz (Chief Financial Officer)

Products/ Services
Pharmaceutical
Number of Employees
1,000 - 20,000
Headquarters
Grünwald, Bayern, Germany
Established
1991
Net Income
100M - 500M
Revenue
Above - 1B
Traded as
DMP.F
Fri Feb 23 2024
About

businessabc offers a global business, SMEs wiki directory blockchain, NFTs, AI powered marketplace for businesses worldwide.

Follow Us
Produced by
In collaboration with
Logo

Copyright 2023 © businessabc powered by ztudium